|
子宫内膜癌的早期筛查及研究进展
|
Abstract:
子宫内膜癌(endometrial cancer, EC)的发病率不断升高,发病年龄趋于年轻化,但生存率没有明显改善。早期诊断及治疗子宫内膜癌与较好的生存预后相关,但目前缺乏准确可靠的筛查方式。临床主要通过妇科超声观察子宫内膜病变,对结果异常的患者进行有创性子宫内膜组织活检来排除子宫内膜恶性病变,经济成本高,患者耐受性差。因此,寻找安全、微创、准确且经济的筛查手段,对提高子宫内膜癌的早期诊断率及改善患者预后至关重要。随着子宫内膜微创取样技术、肿瘤相关生物学分子检测等技术的发展,许多具有EC预测价值的新型标志物被发现和验证,有助于临床为EC高危患者选择最优个性化筛查方案。本文就目前子宫内膜癌早期筛查方式进行综述。
In recent years, the incidence of endometrial cancer (EC) has been increasing and showing a younger trend. Early EC is associated with a better survival prognosis, but there is a lack of accurate and reliable screening methods. In clinical practice, gynecologic ultrasound was used to examine high-risk groups of endometrial cancer, and endometrial tissue biopsy was performed for patients with abnormal results to exclude malignant lesions of endometrial. Such invasive procedures are painful and economically costly for patients. Therefore, we need to find safe, minimally invasive, accurate and inexpensive screening methods for endometrial cancer, which is crucial to improve the early diagnosis rate of endometrial cancer and improve the prognosis of patients. With the development of minimally invasive endometrial sampling technology and tumor-related biological molecular detection technology, more and more novel markers with predictive value of EC have been discovered and validated, which helps clinicians select the most appropriate personalized screening program for patients at high risk of EC. This article reviews the current methods of early screening for endometrial cancer.
[1] | Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R.L., Soerjomataram, I., et al. (2024) Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 74, 229-263. https://doi.org/10.3322/caac.21834 |
[2] | Makker, V., MacKay, H., Ray-Coquard, I., Levine, D.A., Westin, S.N., Aoki, D., et al. (2021) Endometrial Cancer. Nature Reviews Disease Primers, 7, Article No. 88. https://doi.org/10.1038/s41572-021-00324-8 |
[3] | Crosbie, E.J., Kitson, S.J., McAlpine, J.N., Mukhopadhyay, A., Powell, M.E. and Singh, N. (2022) Endometrial Cancer. The Lancet, 399, 1412-1428. https://doi.org/10.1016/s0140-6736(22)00323-3 |
[4] | Pennant, M., Mehta, R., Moody, P., Hackett, G., Prentice, A., Sharp, S., et al. (2016) Premenopausal Abnormal Uterine Bleeding and Risk of Endometrial Cancer. BJOG: An International Journal of Obstetrics & Gynaecology, 124, 404-411. https://doi.org/10.1111/1471-0528.14385 |
[5] | Evans, I., Reisel, D., Jones, A., Bajrami, A., Nijjar, S., Solangon, S.A., et al. (2023) Performance of the WID-qEC Test versus Sonography to Detect Uterine Cancers in Women with Abnormal Uterine Bleeding (EPI-SURE): A Prospective, Consecutive Observational Cohort Study in the UK. The Lancet Oncology, 24, 1375-1386. https://doi.org/10.1016/s1470-2045(23)00466-7 |
[6] | 胡曼琪, 葛继帮, 王伟, 等. 经阴道彩色多普勒超声在子宫内膜息肉和子宫内膜癌鉴别诊断中的应用价值[J]. 中国实用医刊, 2024, 51(8): 78-81. |
[7] | American College of Obstetricians and Gynecologists (2018) ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women with Postmenopausal Bleeding. Obstetrics & Gynecology, 131, 945-946. |
[8] | Wong, A., Lao, T., Cheung, C., Yeung, S., Fan, H., Ng, P., et al. (2015) Reappraisal of Endometrial Thickness for the Detection of Endometrial Cancer in Postmenopausal Bleeding: A Retrospective Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology, 123, 439-446. https://doi.org/10.1111/1471-0528.13342 |
[9] | Kaur, H., Qadri, S., Nevill, A.M. and Ewies, A.A.A. (2024) The Optimal Endometrial Thickness Threshold for Prediction of Endometrial Cancer in Postmenopausal Women without Bleeding Remains Uncertain-Systematic Review and Meta-Analysis. Journal of Gynecology Obstetrics and Human Reproduction, 53, Article ID: 102831. https://doi.org/10.1016/j.jogoh.2024.102831 |
[10] | 高晓泽. 子宫内膜癌经阴道超声的图像特点及其在临床病理分期中的应用价值[J]. 中国冶金工业医学杂志, 2022, 39(5): 505+510. |
[11] | Kumar, K., Pajai, S., Baidya, G.R. and Majhi, K. (2023) Utility of Saline Infusion Sonohysterography in Gynecology: A Review Article. Cureus, 15, e35424. https://doi.org/10.7759/cureus.35424 |
[12] | Frias‐Gomez, J., Benavente, Y., Ponce, J., Brunet, J., Ibáñez, R., Peremiquel‐Trillas, P., et al. (2020) Sensitivity of Cervico‐Vaginal Cytology in Endometrial Carcinoma: A Systematic Review and Meta‐Analysis. Cancer Cytopathology, 128, 792-802. https://doi.org/10.1002/cncy.22266 |
[13] | Raffone, A., Raimondo, D., Raspollini, A., Oliviero, A., Travaglino, A., Santoro, A., et al. (2022) Accuracy of Cytological Examination of Tao Brush Endometrial Sampling in Diagnosing Endometrial Premalignancy and Malignancy. International Journal of Gynecology & Obstetrics, 159, 615-621. https://doi.org/10.1002/ijgo.14204 |
[14] | Yang, X., Ma, K., Chen, R., Meng, Y., Wen, J., Zhang, Q., et al. (2023) A Study Evaluating Liquid-Based Endometrial Cytology Test and Transvaginal Ultrasonography as a Screening Tool for Endometrial Cancer in 570 Postmenopausal Women. Journal of Gynecology Obstetrics and Human Reproduction, 52, Article ID: 102643. https://doi.org/10.1016/j.jogoh.2023.102643 |
[15] | Sakna, N.A., Elgendi, M., Salama, M.H., Zeinhom, A., Labib, S. and Nabhan, A.F. (2023) Diagnostic Accuracy of Endometrial Sampling Tests for Detecting Endometrial Cancer: A Systematic Review and Meta-Analysis. BMJ Open, 13, e072124. https://doi.org/10.1136/bmjopen-2023-072124 |
[16] | Adambekov, S., Goughnour, S.L., Mansuria, S., Donnellan, N., Elishaev, E., Villanueva, H.J., et al. (2017) Patient and Provider Factors Associated with Endometrial Pipelle Sampling Failure. Gynecologic Oncology, 144, 324-328. https://doi.org/10.1016/j.ygyno.2016.11.041 |
[17] | Vermorgen, S., Gelton, T., Bult, P., Kusters-Vandevelde, H.V.N., Hausnerová, J., Van de Vijver, K., et al. (2024) Endometrial Pipelle Biopsy Computer-Aided Diagnosis: A Feasibility Study. Modern Pathology, 37, Article ID: 100417. https://doi.org/10.1016/j.modpat.2023.100417 |
[18] | Terzic, M.M., Aimagambetova, G., Terzic, S., Norton, M., Bapayeva, G. and Garzon, S. (2020) Current Role of Pipelle Endometrial Sampling in Early Diagnosis of Endometrial Cancer. Translational Cancer Research, 9, 7716-7724. https://doi.org/10.21037/tcr.2020.04.20 |
[19] | Di Spiezio Sardo, A., Saccone, G., Carugno, J., Pacheco, L.A., Zizolfi, B., Haimovich, S., et al. (2022) Endometrial Biopsy under Direct Hysteroscopic Visualisation versus Blind Endometrial Sampling for the Diagnosis of Endometrial Hyperplasia and Cancer: Systematic Review and Meta-Analysis. Facts, Views and Vision in ObGyn, 14, 103-110. https://doi.org/10.52054/fvvo.14.2.023 |
[20] | Stachowicz, N., Mazurek, D., Łoziński, T. and Czekierdowski, A. (2017) Diagnostic Hysteroscopy and the Risk of Malignant Cells Intraabdominal Spread in Women with Endometrial Cancer. Ginekologia Polska, 88, 562-567. https://doi.org/10.5603/gp.a2017.0101 |
[21] | Behrouzi, R., Barr, C.E. and Crosbie, E.J. (2021) HE4 as a Biomarker for Endometrial Cancer. Cancers, 13, Article No. 4764. https://doi.org/10.3390/cancers13194764 |
[22] | Yuan, J., Xu, C., Liu, C. and Yan, R. (2024) Diagnostic Value of Serum Human Epididymal Secretory Protein 4 for Endometrial Cancer: A Systematic Review and Meta-Analysis. Discover Oncology, 15, Article No. 498. https://doi.org/10.1007/s12672-024-01234-3 |
[23] | 祁晓莉, 张立英, 马秀华, 谢丽梦, 王彦, 卢晓红. 子宫内膜癌PTEN的表达及其与临床病理特征的关系[J]. 临床和实验医学杂志, 2019, 18(22): 2413-2416. |
[24] | Ashley, C.W., Selenica, P., Patel, J., Wu, M., Nincevic, J., Lakhman, Y., et al. (2022) High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer. Clinical Cancer Research, 29, 410-421. https://doi.org/10.1158/1078-0432.ccr-22-1134 |
[25] | Fiala, C. and Diamandis, E.P. (2018) Utility of Circulating Tumor DNA in Cancer Diagnostics with Emphasis on Early Detection. BMC Medicine, 16, Article No. 166. https://doi.org/10.1186/s12916-018-1157-9 |
[26] | Gao, J., Fan, Y., Gao, S. and Zhang, W. (2022) Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: A Meta‐Analysis. Reproductive Sciences, 30, 464-472. https://doi.org/10.1007/s43032-022-01019-5 |
[27] | 赵行平, 徐大宝, 马洁稚, 傅英钦, 李斌玉, 靳希桐, 等. DNA甲基化检测在育龄期异常子宫出血女性子宫内膜癌诊断中的应用价值[J]. 中华检验医学杂志, 2023, 46(4): 367-374. |
[28] | Qi, B., Sun, Y., Lv, Y., Hu, P., Ma, Y., Gao, W., et al. (2023) Hypermethylated CDO1 and CELF4 in Cytological Specimens as Triage Strategy Biomarkers in Endometrial Malignant Lesions. Frontiers in Oncology, 13, Article ID: 1289366. https://doi.org/10.3389/fonc.2023.1289366 |
[29] | Barrett, J.E., Jones, A., Evans, I., Herzog, C., Reisel, D., Olaitan, A., et al. (2023) The WID-EC Test for the Detection and Risk Prediction of Endometrial Cancer. International Journal of Cancer, 152, 1977-1988. https://doi.org/10.1002/ijc.34406 |
[30] | 李莉, 谢涵, 胡婷, 周虎, 李希, 陈刚. 不同采样方法在子宫内膜癌甲基化检测辅助诊断中的效能比较[J]. 现代妇产科进展, 2023, 32(12): 881-884. |
[31] | Li, M., Xia, Z., Wang, R., Xi, M. and Hou, M. (2025) Unveiling DNA Methylation: Early Diagnosis, Risk Assessment, and Therapy for Endometrial Cancer. Frontiers in Oncology, 14, Article ID: 1455255. https://doi.org/10.3389/fonc.2024.1455255 |
[32] | Schiemer, R., Furniss, D., Phang, S., Seddon, A.B., Atiomo, W. and Gajjar, K.B. (2022) Vibrational Biospectroscopy: An Alternative Approach to Endometrial Cancer Diagnosis and Screening. International Journal of Molecular Sciences, 23, Article No. 4859. https://doi.org/10.3390/ijms23094859 |
[33] | Barnas, E., Skret-Magierlo, J., Skret, A., Kaznowska, E., Depciuch, J., Szmuc, K., et al. (2020) Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer. International Journal of Molecular Sciences, 21, Article No. 4828. https://doi.org/10.3390/ijms21144828 |
[34] | Paraskevaidi, M., Morais, C.L.M., Ashton, K.M., Stringfellow, H.F., McVey, R.J., Ryan, N.A.J., et al. (2020) Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study. Cancers, 12, Article No. 1256. https://doi.org/10.3390/cancers12051256 |